drugset / Trial / NCT03838250
Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the safety and efficacy of a single dose of Cellgram™ delivered via hepatic artery in patients with decompensated alcoholic liver cirrhosis.
Timeline
- Start
- 2019-06-20
- Primary completion
- 2021-03
- Completion
- 2021-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous bone marrow-derived mesenchymal stem cells | Cell therapy | 5e+07 cells | Other |